British Journal of Dermatology

Papers
(The H4-Index of British Journal of Dermatology is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Integrating artificial intelligence into skin cancer pathways: the opportunities and obstacles284
352 Efficacy and safety of abrocitinib in Chinese patients with moderate-to-severe atopic dermatitis: a post-hoc analysis of the JADE REGIMEN phase 3 trial221
335 Improvement in sleep quality, anxiety and depression in adults with moderate-to-severe atopic dermatitis with dupilumab treatment177
Greater understanding about differences in the long-term course of eczema and their risk factors in children94
Epidemiology, comorbidities and mortality of pyoderma gangrenosum: new insights92
520 - Evaluating the expression of OX40 and OX40 ligand in lesional skin versus non-lesional skin in volunteers with atopic dermatitis and in healthy control skin75
561 - Dupilumab treatment reduces signs in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial74
Higher proportion of cellulitis in severe lymphoedema73
691 - Understanding patient and physician preferences when choosing between biologic and oral systemic treatment options for moderate-to-severe atopic dermatitis: a discrete choice experiment71
643 - Effectiveness and safety of upadacitinib in adolescent and adult patients with atopic dermatitis: an analysis of short-term (week 8-20) data from a real-world multicenter retrospective review70
677 - Establishing a patient-centered definition of atopic dermatitis flare: insights from a modified eDelphi study70
673 - Efficacy of nemolizumab in different subgroups of patients with prurigo nodularis in two randomized, placebo-controlled phase 3 trials68
641 - Pooled efficacy, patient-reported outcomes, and safety of roflumilast cream 0.15% from the INTEGUMENT-1 and INTEGUMENT-2 phase 3 trials of adults and children with atopic dermatitis67
粒细胞集落刺激因子在化脓性汗腺炎中的作用65
603 - Ruxolitinib cream 1.5% twice daily for the treatment of extensive atopic dermatitis in children aged 2–11 years: 52 week results from a maximum-use trial65
PS04: Burden of treatment in adult patients with atopic dermatitis62
BH08: A rare and incidental finding of pili multigemini of the back60
P51: Socioeconomic factors influence severity rather than incidence of dermatoses60
P79: A review of proton pump inhibitor photosensitivity in a tertiary referral photodiagnostic centre59
PA07: Scratching the surface: a review of online misinformation and conspiracy theories in paediatric atopic dermatitis58
PD16: Behaviours, attitudes and the importance of sun safety via an Arduino development kit57
对化疗所致脱发的更深入了解56
一项在一家大型教学医院进行的 5 年皮肤附属器肿瘤研究, 对关联基因诊断提供了启示56
空气污染会导致皮肤颜色变深54
BG02: Muir‐Torre syndrome: a case of unusual coexisting genetic mutations53
BT06: Reporting time in two different teledermatology platforms53
P100: Efficacy of current treatments under study in patients with alopecia areata52
Recognizing psoriasis in children and adolescents: the DIPSOC study51
BH13: Scarring alopecia affecting a congenital melanocytic naevus in a patient with frontal fibrosing alopecia50
P15: Twenty years of the UK Dermatology Clinical Trials Network: past, present and future49
CPC11: Bromoderma in a patient with chronic obstructive pulmonary disease49
开展健康宣传活动,禁售日光浴床,以减少皮肤癌: 合理利用医疗预算48
P57: New order: redesigning referral pathways to improve access for patients from dermatology outpatient waiting lists48
H10: A Sweet diagnosis to make: the history of Robert Douglas Sweet and acute febrile neutrophilic dermatosis47
BH09: Frontal fibrosing alopecia in men: is it any different?46
Issue Information46
P52: Opportunities for implementing a patient‐initiated follow‐up pathway in patients with psoriasis completing narrowband ultraviolet B phototherapy46
Issue Information44
PS11: Severe suicidal attempt secondary to allergic contact dermatitis in a noncompliant patient43
Possible new oral treatment for hidradenitis suppurativa42
News and Notices42
BT08: Assessment of three different dermoscopy imaging systems during a fast‐track skin cancer clinic42
0.14391398429871